BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 17144911)

  • 1. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
    Riggs NL; Little SJ; Richman DD; Guatelli JC
    Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    O'Reilly MM; McNally MT; Beemon KL
    Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression.
    Itoh M; Inoue J; Toyoshima H; Akizawa T; Higashi M; Yoshida M
    Oncogene; 1989 Nov; 4(11):1275-9. PubMed ID: 2682457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA.
    Benko DM; Robinson R; Solomin L; Mellini M; Felber BK; Pavlakis GN
    New Biol; 1990 Dec; 2(12):1111-22. PubMed ID: 2088501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Cis Enhancing Sequence (CES) enhances CTE-dependent Gag expression.
    Suptawiwat O; Lee TH; Auewarakul P
    Virology; 2005 Nov; 342(1):111-8. PubMed ID: 16125747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Madsen JM; Stoltzfus CM
    Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
    Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
    J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron.
    Haut DD; Pintel DJ
    Virology; 1999 May; 258(1):84-94. PubMed ID: 10329570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence.
    Asang C; Erkelenz S; Schaal H
    Virology; 2012 Oct; 432(1):133-45. PubMed ID: 22749061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.